Onconova Therapeutics Inc (NASDAQ: TRAW) stock enjoyed a major increase of 150.4% on 12/23/24. The shares closed at $12.57. Moreover, exceptionally high trading volume at 4825% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 170.3% during the last week.
Current PriceTarget Research Rating
Onconova Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Onconova Therapeutics has a very low Power Rating of 3 and a very low Appreciation Score of 0, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment